INS and obesity disorder: CAP modulated the fasting blood glucose and insulin concentrations as well as decreased the levels of proinflammatory cytokines interleukin-1β and interleukin-6 to treat high-fat, or high-sucrose (HFHS) diet-induced obesity (Marics et al., 2017).